Clinical Trials Browser

INDUSTRY × Interventional × rocakinogene sifuplasmid × Clear all

NCT03491683 2026-05-04

INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)

Phase 1/2 Active not recruiting

Glioblastoma

NCT03502785 2025-07-10

INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma

Phase 1/2 Completed

Carcinoma, Transitional Cell

NCT02172911 2021-02-21

A Study of INO-3112 DNA Vaccine With Electroporation in Participants With Cervical Cancer

Phase 1/2 Completed

10 enrolled 19 charts

Uterine Cervical Neoplasms

NCT02163057 2021-01-22

Study of HPV Specific Immunotherapy in Participants With HPV Associated Head and Neck Squamous Cell Carcinoma

Phase 1/2 Completed

22 enrolled 14 charts

Head and Neck Squamous Cell Cancer

NCT02960594 2018-11-19

TRT-001

Phase 1 Completed

BreastGastrointestinalGynecologicHead & NeckThoracic

Breast Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT02241369 2018-11-16

Immunotherapy in Subjects With HPV-6 Associated Aerodigestive Precancerous Lesions and Malignancies

Phase 1 Completed

Carcinoma, Squamous Cell, Neoplasms

NCT02514213 2017-12-26

Trial to Evaluate Safety and Immunogenicity of INO-5150 Alone or With INO-9012 in Men With Prostate Cancer

Phase 1 Completed

Prostatic Neoplasms